Evidence review · standard

dihexa

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `dihexa`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/dihexa

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/dihexa/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/dihexa/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/dihexa/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/dihexa/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

Regeneration vs degeneration — where this fits

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

What it is

2026 review discusses dihexa among neuroactive peptides for potential neuroplasticity benefits via HGF/c-Met and BDNF pathways, noting promising preclinical data but absence of clinical trials. 2024 preclinical study examining Dihexa (as PNB-0408) in a rat model of 3-nitropropionic acid-induced neurotoxicity modeling Huntington’s disease, highlighting its neuroprotective properties.

How it works

Step logic:

  1. 2026 review discusses dihexa among neuroactive peptides for potential neuroplasticity benefits via HGF/c-Met and BDNF pathways, noting promising preclinical data but absence of clinical trials.

Why it would work (logic chain)

  1. IF 2026 review discusses dihexa among neuroactive peptides for potential neuroplasticity benefits via HGF/c-Met and BDNF pathways, noting promising preclinical data but absence of clinical trials. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  2. IF 2024 preclinical study examining Dihexa (as PNB-0408) in a rat model of 3-nitropropionic acid-induced neurotoxicity modeling Huntington’s disease, highlighting its neuroprotective properties. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).

How many people take it

There is no reliable global count of how many people take this compound. That number is not in this ledger.

What we can count from this ledger:

  • 0 anecdote source(s) (posts, threads, comments)
  • 0 anecdote-tier claim(s) derived from them

Logic: Without catalogued Reddit/X posts, this article cannot answer how many people take it — only what studies exist.

Evidence inventory

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 2
  • Claims tagged human evidence: 0
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 2

Logic: Studies exist in the ledger, but none are graded as strong human proof for the uses people discuss online. Animal and lab work is not the same as proof in people.

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.13 / 1.00 — very low

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions (source s1)

2026 review discusses dihexa among neuroactive peptides for potential neuroplasticity benefits via HGF/c-Met and BDNF pathways, noting promising preclinical data but absence of clinical trials.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Effects of an Angiotensin IV Analog on 3-Nitropropionic Acid-Induced Neurotoxicity in Rats (source s2)

2024 preclinical study examining Dihexa (as PNB-0408) in a rat model of 3-nitropropionic acid-induced neurotoxicity modeling Huntington’s disease, highlighting its neuroprotective properties.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Dihexa · peptide map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpBenzo WithdrawalBenzodiazepinesBrain FogCarpal Tunnel
Evidence · 2 sources · swipe →chain 31d58be61bff · verify chain · provenance
1 / 2
Evidence ledger 2 · tier-ranked · API
preclinical
2026 review discusses dihexa among neuroactive peptides for potential neuroplasticity benefits via HGF/c-Met and BDNF pathways, noting promising preclinical data but absence of clinical trials.
sources: s1
preclinicallow confidence
2024 preclinical study examining Dihexa (as PNB-0408) in a rat model of 3-nitropropionic acid-induced neurotoxicity modeling Huntington’s disease, highlighting its neuroprotective properties.
sources: s2
Model swipes · 3 from 1 model · swipe →verify
1 / 3
grok-4.3writer
draft2026-06-29 16:52
dihexa
inspect — what it was prompted & output
prompted with
(default writer prompt)
4523073954717382
grok-4.3source_hunt
sources2026-06-29 16:53
1 source(s) added · 1 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: dihexa
it output
1 source(s) added
efe6576cf576aed5
grok-4.3source_hunt
sources2026-06-29 16:53
1 source(s) added · 1 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: dihexa
it output
1 source(s) added
f089cb67c3670b5b

Related research

Dihexa · peptide map

Open evidence map →
Benzo Withdrawaldihexa-benzo-withdrawalBenzodiazepinesdihexa-benzodiazepinesBrain Fogdihexa-brain-fogCarpal Tunneldihexa-carpal-tunnelChemodihexa-chemoChemo Neuropathydihexa-chemo-neuropathyCognitiondihexa-cognitionCorticosteroidsdihexa-corticosteroidsDiabetic Neuropathydihexa-diabetic-neuropathyFrozen Shoulderdihexa-frozen-shoulder
Ask this article · 4 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (preclinical tier): "2026 review discusses dihexa among neuroactive peptides for potential neuroplasticity benefits via HGF/c-Met and BDNF pathways, noting promi…"?
ask dihexa claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "2024 preclinical study examining Dihexa (as PNB-0408) in a rat model of 3-nitropropionic acid-induced neurotoxicity modeling Huntington’s di…"?
ask dihexa claim c2 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about dihexa — and what would you need me to tell you first?
ask dihexa condition gaps · paste includes §SELF
What good and bad outcomes are documented for dihexa (studies vs anecdotes)?
ask dihexa good bad experiences · paste includes §SELF
dihexa · posted 2026-06-29 · updated 2026-06-29 · 2 prior revisions
Ledger API & provenance
Provenance · 3 model passes · 0 tokens · $0 · 1 model
chain head 10088c4e03e09566
populate-init grok-4.3 · 2026-06-29 16:52 · 0 tok · 28962d4dca87
sources grok-4.3 · 2026-06-29 16:53 · 0 tok · ea13d65b4ebc
sources grok-4.3 · 2026-06-29 16:53 · 0 tok · 10088c4e03e0
verify chain →
Live ledger · 7 payloads · 2 turns
recent activity · inspect
send blooio · 2026-06-13 16:10
TWOCHAT_SEND 2chat · 2026-06-13 16:10 · t_ipp56bzz
TWOCHAT_SEND 2chat · 2026-06-13 16:10 · t_ipp56bzz
ROUTER grok · 2026-06-13 16:10 · t_3hkrqlg2
ROUTER grok · 2026-06-13 16:10 · t_3hkrqlg2
ROUTER grok · 2026-06-13 16:10 · t_3hkrqlg2
view full ledger & cards →
REST + ledger
read GET /api/articles/dihexa · GET /api/articles/dihexa?format=post (the editable body)
create/replace POST /api/articles/dihexa · PUT /api/articles/dihexa (replace, keeps revision) · PATCH /api/articles/dihexa (merge)
delete DELETE /api/articles/dihexa
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/dihexa/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/dihexa/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim dihexa|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →